SXI Life Sciences
7.670,04
PKT
-74,54
PKT
-0,96
%
Werbung
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 18.05.12 | Novartis hold | Vontobel Research | |
| 17.05.12 | Novartis buy | Société Générale Group S.A. (SG) | |
| 16.05.12 | Newron PharmaceuticalsAz. buy | Vontobel Research | |
| 16.05.12 | Straumann hold | Vontobel Research | |
| 15.05.12 | Newron PharmaceuticalsAz. buy | Vontobel Research | |
| 10.05.12 | Novartis buy | Société Générale Group S.A. (SG) | |
| 10.05.12 | Straumann hold | Vontobel Research | |
| 08.05.12 | Lonza kaufen | Die Actien-Börse | |
| 07.05.12 | Lonza hold | Vontobel Research | |
| 04.05.12 | Novartis neutral | Banc of America Securities-Merrill Lynch | |
| 04.05.12 | Novartis buy | UBS AG | |
| 04.05.12 | Lonza neutral | Sarasin Research | |
| 04.05.12 | Lonza underperform | Cheuvreux SA | |
| 04.05.12 | Lonza hold | Vontobel Research | |
| 03.05.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 03.05.12 | Novartis hold | Vontobel Research | |
| 30.04.12 | Novartis hold | Vontobel Research | |
| 26.04.12 | Straumann hold | Vontobel Research | |
| 26.04.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 25.04.12 | Novartis kaufen | Hamburger Sparkasse AG (Haspa) | |
| 25.04.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 25.04.12 | Novartis hold | Vontobel Research | |
| 24.04.12 | Novartis buy | WestLB AG | |
| 24.04.12 | Novartis halten | Independent Research GmbH | |
| 24.04.12 | Novartis buy | Sarasin Research | |
| 24.04.12 | BB Biotech buy | Close Brothers Seydler Research AG | |
| 24.04.12 | Novartis underperform | Cheuvreux SA | |
| 24.04.12 | Novartis hold | Vontobel Research | |
| 23.04.12 | Novartis buy | Nomura | |
| 23.04.12 | Novartis buy | Sarasin Research | |
| 19.04.12 | BB Biotech kaufen | Independent Research GmbH | |
| 11.04.12 | Novartis buy | UBS AG | |
| 10.04.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 10.04.12 | Sonova kaufen | Die Actien-Börse | |
| 03.04.12 | Lonza neutral | Sarasin Research | |
| 03.04.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 02.04.12 | Novartis buy | Sarasin Research | |
| 27.03.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 22.03.12 | Straumann neutral | Sarasin Research | |
| 21.03.12 | Novartis buy | Deutsche Bank AG |